Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

P. E. Goss, J. N. Ingle, S. Martino, N. J. Robert, H. B. Muss, R. B. Livingston, N. E. Davidson, E. A. Perez, Y. Chavarri-Guerra, D. A. Cameron, K. I. Pritchard, T. Whelan, L. E. Shepherd, D. Tu

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole'. Together they form a unique fingerprint.

Medicine & Life Sciences